Bio-Reference Labs (NASDAQ:BRLI): FQ2 EPS of $0.41 in-line. Revenue of $176.4M. (PR)
Bio-Reference Labs (NASDAQ:BRLI): FQ2 EPS of $0.41 in-line. Revenue of $176.4M. (PR)
Recommended For You
More Trending News
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BRLI-OLD | - | - |
| Bio-Reference Laboratories | ||